Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Shinjiro Takagi"'
Autor:
Jun Kato, Masahiro Takahara, Kazuhiro Matsueda, Toshihiro Inokuchi, Reiji Higashi, Seiyuu Suzuki, Yuki Moritou, Sakiko Hiraoka, Akiko Fujiwara, Tatsuya Toyokawa, Shinjiro Takagi, Hiroyuki Okada, Jiro Miyaike
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:137-143
BACKGROUND AND AIM Although oral mesalamine is the first-choice drug for treating mild-to-moderate ulcerative colitis (UC), some patients show symptoms of intolerance, including exacerbation of diarrhea and abdominal pain. The present study clarified
Autor:
Shogo Kimura, Yusuke Kurioka, Shinjiro Takagi, Ukyo Okazaki, Masahiro Takatani, Hirofumi Morishita, Yu Matsuo, Toshihiko Matsumoto, Takao Tsuduki, Kou Miura
Publikováno v:
Pancreas. 49:574-578
Objectives There is no standard chemotherapy for advanced pancreatic cancer (APC) after gemcitabine plus nab-paclitaxel (GP) failure. The aim of this study was to evaluate the efficacy and safety of FOLFIRINOX (5-Fluorouracil, leucovorin, irinotecan,
Autor:
Toshihiko Matsumoto, Hirofumi Morishita, Yu Yoshida, Masahiro Takatani, Shinjiro Takagi, Shogo Kimura, Takao Tsuduki, Hitomi Himei, Takashi Oda
Publikováno v:
Int Cancer Conf J
Takotsubo cardiomyopathy (TCM) is also known as stress-induced cardiomyopathy. The occurrence of TCM due to infusion reaction is extremely rare. A 65-year-old man began receiving trastuzumab monotherapy for gastric cancer. However, he developed an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c5241540fb134acc23bc00bba91f72
https://europepmc.org/articles/PMC6942559/
https://europepmc.org/articles/PMC6942559/
Autor:
Hiroki Nagai, Shinjiro Takagi, Masahiro Takatani, Kou Miura, Hisateru Yasui, Toshihiko Matsumoto, T. Ikoma, Takao Tsuzuki
Publikováno v:
Annals of Oncology. 32:S299
Autor:
Jun Kato, Kazuhiro Matsueda, Toshihiro Inokuchi, Tatsuya Toyokawa, Hiroyuki Okada, Reiji Higashi, Sakiko Hiraoka, Seiyu Suzuki, Jiro Miyaike, Masahiro Takahara, Akiko Fujiwara, Shinjiro Takagi, Yuki Moritou
Publikováno v:
Gastroenterology. 158:S-679
Autor:
Takao Tsuzuki, Hirofumi Morishita, Ukyo Okazaki, Shinjiro Takagi, Toshihiko Matsumoto, Shogo Kimura, Yusuke Kurioka, Masahiro Takatani
Publikováno v:
Journal of Clinical Oncology. 38:391-391
391 Background: Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcome compared to best supportive care in AGC patients who received at least two prior regimen. Although there is not reliable date of poor
Autor:
Sakiko Hiraoka, Mamoru Nishimura, Jiro Miyaike, Koji Takemoto, Tatsuya Toyokawa, Reiji Higashi, Seiyuu Suzuki, Hiroyuki Okada, Yuki Morito, Jun Kato, Masafumi Inoue, Sakuma Takahashi, Shinjiro Takagi, Tsuyoshi Fujimoto, Toru Nawa, Toshihiro Inokuchi
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 34(8)
Background and aim Although previous studies compared the efficacy of infliximab (IFX) versus adalimumab (ADA) as the first-line biologics for Crohn's disease (CD), the difference in long-term prognosis based on which biologic was used first has scar
Autor:
Shinjiro Takagi
Publikováno v:
International Insolvency Review. 22:55-59
The INSOL 8 Principles is a set of model domestic rules for out-of-court workouts. Many Asian countries have created workout rules referring to the Principles. A uniform insolvency code applicable worldwide may be impossible to achieve. Instead, inte
Place of death in gastrointestinal cancer patients: Retrospective study in Japanese general hospital
Autor:
Shinjiro Takagi, Hirofumi Morishita, Masahiro Takatani, Hitomi Himei, Takao Tsuzuki, Toshihiko Matsumoto, Shogo Kimura
Publikováno v:
Journal of Clinical Oncology. 36:e22189-e22189
e22189Background: Place of death is widely known that it is important factor for quality of life of advanced cancer patients and caregivers. Although there are few studies that examine gastrointest...
Autor:
Shinjiro Takagi
Publikováno v:
International Insolvency Review. 16:95-101
As a basic principle, subject to defined exceptions, the effects of a bankruptcy proceeding commenced under Chapter 15 should be restricted to assets of the debtor located within the territorial jurisdiction of the United States. But Section 1528 pro